Home Cart Sign in  
Chemical Structure| 84294-96-2 Chemical Structure| 84294-96-2

Structure of Enoxacin Sesquihydrate
CAS No.: 84294-96-2

Chemical Structure| 84294-96-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Enoxacin Sesquihydrate is a broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea, working by inhibiting bacterial DNA gyrase and topoisomerase IV.

Synonyms: CI-919 hydrate; AT-2266 hydrate; Enoxacin hydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Enoxacin Sesquihydrate

CAS No. :84294-96-2
Formula : C30H40F2N8O9
M.W : 694.68
SMILES Code : O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCNCC3)=N2)C1=O)O.[H]O[H].O=C(C4=CN(CC)C5=C(C=C(F)C(N6CCNCC6)=N5)C4=O)O.[H]O[H].[H]O[H]
Synonyms :
CI-919 hydrate; AT-2266 hydrate; Enoxacin hydrate
MDL No. :MFCD01747755
InChI Key :DKNNITGJCMPHKE-UHFFFAOYSA-N
Pubchem ID :24840537

Safety of Enoxacin Sesquihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
C2C12 myotubes 100 μM During differentiation Upregulated Ppargc1a and oxidative metabolism-related genes, increased maximum mitochondrial respiration and proton leak Sci Adv. 2020 Dec 2;6(49):eabc6250
Human adipose-derived stem cells (hASC) 50 μM 10 days after differentiation Increased UCP1 and PPARGC1A mRNA levels Sci Adv. 2020 Dec 2;6(49):eabc6250
Mouse brown preadipocytes (9B) 50 μM During differentiation Increased Elovl3 expression but did not affect Ucp1 and Ppargc1a Sci Adv. 2020 Dec 2;6(49):eabc6250
Mouse subcutaneous preadipocytes (9W) 50 μM During differentiation (days 2 to 8) Promoted expression of brown/beige adipocyte markers (Ucp1, Dio2, Prdm16, Ppargc1a) Sci Adv. 2020 Dec 2;6(49):eabc6250
human neural progenitor cells (hNPCs) 100 µM 48 hours To evaluate the inhibitory effect of Enoxacin on ZIKV infection, results showed that Enoxacin significantly inhibited ZIKV replication in hNPCs Cell Res. 2019 Apr;29(4):265-273
HCT-116 cells 40 μg/mL (124 μM) Enoxacin showed dose-dependent growth inhibition in HCT-116 cells Redox Biol. 2018 Sep;18:84-92
NSC-34 cells 100 μM 72 hours To test whether enoxacin could reverse the negative effect of ALS-causing mutant proteins on miRNA processing. Results showed that enoxacin partially ameliorated the impairments in pre-miRNA processing induced by ALS-causing mutants FUS R495X, TDP-43 A315T, or SOD1 G93A. EMBO J. 2015 Nov 3;34(21):2633-51
SW1736 cells 40 µg/mL 5 days Enoxacin significantly inhibited proliferation, migration, and invasion in SW1736 cells, and decreased the expression of EMT markers. Oncogene. 2019 Jul;38(27):5486-5499
TPC1 cells 40 µg/mL 5 days Enoxacin significantly inhibited proliferation, migration, and invasion in TPC1 cells, and decreased the expression of EMT markers. Oncogene. 2019 Jul;38(27):5486-5499
Cal62 cells 40 µg/mL 5 days Enoxacin significantly inhibited proliferation, migration, and invasion in Cal62 cells, and decreased the expression of EMT markers. Oncogene. 2019 Jul;38(27):5486-5499
Human primary lung epithelial cells 200 μM 48 hours Enoxacin reduced the expression of squamous differentiation markers induced by Doxorubicin Cell Death Discov. 2023 Jan 21;9(1):21
Human primary lung epithelial cells 200 μM 24 hours Enoxacin attenuated DNA damage and squamous differentiation response induced by Doxorubicin by enhancing DNA repair Cell Death Discov. 2023 Jan 21;9(1):21

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice (C57BL/6) High-fat diet-induced obesity model Intraperitoneal injection 10 mg/kg body weight/day 5 times/week for 10 weeks Mitigated obesity, increased energy expenditure, improved glucose tolerance and insulin sensitivity, promoted BAT activation and beige adipogenesis Sci Adv. 2020 Dec 2;6(49):eabc6250
Caenorhabditis elegans (C. elegans) Wild-type N2 Bristol and other mutants Added to NGM medium 100 μg/mL Continuous administration starting from day 0 of adulthood Enoxacin extended the lifespan of C. elegans and promoted survival under normal and oxidative stress conditions, achieved by inhibiting miR-34-5p and promoting mitohormesis. Redox Biol. 2018 Sep;18:84-92
Mice SOD1 G93A ALS mouse model Oral 800 mg/kg bodyweight/day Once daily, starting from day 42 To test whether enoxacin has a beneficial effect on neuromuscular function in the SOD1 G93A mouse model of ALS. Results showed that the enoxacin-treated group had a ~7-day delay in the onset of neurological symptoms, weight peak, and onset of weight decline compared to the control group. The neurological score was superior in the enoxacin-treated cohort, and performance was better in rotarod tests and gait analysis. EMBO J. 2015 Nov 3;34(21):2633-51
Mice Orthotopic mouse model of human thyroid cancer Intraperitoneal injection 15 mg/kg Daily over 28 days Enoxacin significantly diminished tumor growth, upregulated the expression of critical miRNAs in tumors, and downregulated the EMT markers fibronectin and N-cadherin and the proliferation marker PCNA. Oncogene. 2019 Jul;38(27):5486-5499
Female C57BL/6 mice DHEA-induced PCOS mouse model Intraperitoneal injection 100 mg/kg/day Once daily for 3 weeks Enoxacin ameliorated reproductive endocrine disorder, glucose intolerance, and ovarian dysfunction in DHEA-induced PCOS mice. By promoting white fat browning and improving metabolic disorders, it ameliorated DHEA-induced reproductive dysfunction. These beneficial effects might be associated with the restoration of gut dysbiosis. Front Pharmacol. 2022 Sep 6;13:978019

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.44mL

0.29mL

0.14mL

7.20mL

1.44mL

0.72mL

14.40mL

2.88mL

1.44mL

References

 

Historical Records

Categories